The immuno-pathological mechanisms underlying SSc—vasoconstriction, as well as pro-inflammatory, proliferative, and profibrotic effects—are closely associated with the molecular events mediated by Ang II and ET1 through AT1R and ETAR, respectively. The gene discussed is EDNRA; the disease is systemic sclerosis.